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Neovalve construction in deep venous incompetence
Marzia Lugli, MD,a Sara Guerzoni, BS,a Mariano Garofalo, MD,a Gianluca Smedile, MD,b and
Oscar Maleti, MD,a Modena and Rome, Italy
Objectives: The purpose of this study is to assess the outcome of neovalve construction in two consecutive series of patients
affected by postthrombotic syndrome and valve agenesis. The technique was modified in the second series so as to correct
a cause of failure.
Methods: Between December 2000 and June 2007, 40 neovalve constructions were carried out in 36 patients (19 males,
17 females, median age 57, range, 29-82) affected by deep venous insufficiency. Thirty-two patients were affected by
postthrombotic syndrome and 4 by valve agenesis. The 32 patients with postthrombotic syndrome were selected from
among 76 patients with resistant ulcers classified C 6,S E S A S,D,P P R,RO and the 4 patients with valve agenesis were
selected from among 28 affected by resistant ulcers classified as C 6,S E C A S,D,P P R. The patients were subdivided into
2 groups. The first group included 19 operations performed in the period between December 2000 and December 2004,
with a median follow-up of 54 months (range, 31-78). The second group included 21 patients operated on between
January 2005 and June 2007, with a median follow-up of 5 months (range, 2-29). In the second group, a surgical
variation was applied in order to prevent flap collapse and to maintain the continence of the neovalve.
Results: In the first series, ulcer healing was observed in 16 cases out of 19 (84%). Recurrent ulcers were observed in one
case after 3 years. Valve competence was ascertained in 13 cases per 803 patient-months (1.6/100 patient-months). With
regard to the second series, competence was achieved in all cases with a cumulative rate of 21 per 228 patient-months
(9.2/100 patient-months). In the second series, the ulcer failed to heal in one case and recurred in two cases, with an
intention-to-treat ulcer recurrence rate of three cases per 209 patient-months. Postoperative deep-venous thrombosis was
observed in 3 patients in the first series. None was detected in the second series. The mortality rate was 0 and in neither
group was pulmonary embolism detected.
Conclusion: The modified technique applied to the second group seemed to improve valve continence results significantly.
However, a longer follow-up period is required for the latter group to validate this technical enhancement. (J Vasc Surg
2009;49:156-62.)Severe chronic venous insufficiency is a widely recog-
nized cause of incapacity. Significant symptoms and trophic
lesions markedly reduce the quality of life of patients af-
fected. The most serious forms are those related to pathol-
ogies affecting the deep venous system, predominantly of
postthrombotic origin1 and, to a lesser extent, primary and
congenital types.2 Compression therapy is the chief way of
treating these patients,3 but it is not always possible to
achieve complete control of the situation, and in selected
patients various treatments can be indicated to restore axial
flow or to neutralize reflux. In cases of valve insufficiency,
the correction of reflux consists principally in reconstruct-
ing the valve or creating an anti-reflux mechanism. This
goal can be achieved using various techniques,4 among
which neovalve construction, as we have previously de-
scribed in detail.5,6 The efficacy of the neovalve as an
anti-reflux mechanism has been demonstrated in the short-
to-medium term.6 However, it was unclear why, in some
cases, neovalves that proved technically efficient at intraop-
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156erative checks and at immediate postoperative venography
failed within a short period after the operation. Veno-
graphic findings of these cases suggested that the probable
cause lay in parietal re-adhesion. Accordingly, we began
treating a second series of patients, modifying the tech-
nique as described below and obtaining improved results.
METHODS AND MATERIALS
Patient selection. From December 2000 to June
2007, 40 consecutive neovalve construction operations
were performed in 36 patients (19 male, 17 female, median
age 57, range, 29-82) affected by deep venous insuffi-
ciency. Five were bicuspid and 35 were monocuspid.
These operations were subdivided into 2 groups, based
on a technical variation. The first series included 19 opera-
tions in 17 patients (9 males, 8 females, median age 55,
range, 34-79 years) performed in the period between De-
cember 2000 and December 2004. The second series in-
cluded 21 operations in 21 patients (12 males, 9 females,
median age 59, range, 29-82). Two patients underwent
operations to both lower limbs and, therefore, fall into both
groups, belonging to the first series for one limb, and to the
second series as regards to the second limb. The two groups
of patients do not present significant statistical differences.
Patient demographics are shown in Table I. All patients
were classified according to CEAP classification.
This sample of patients was selected from among 353
patients observed from January 2000 and classified asC6s (Fig
1, online only). All patients underwent duplex scanning as-
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perforator system. When a deep venous reflux was identified
on ultrasound scan evaluation,7 air plethysmography,8 and in
cases of associated segmental obstruction, occlusion plethys-
mography was performed. Ultrasound scanning was con-
ducted using the standard technique, with patients in the
standing position. The reflux was detected with the sleeve
placed at calf level, and subsequently with the patient in the
supine position we performed the exploration of the entire
axis. All patients with deep venous reflux were then submitted
to ascending and descending venography, using the crossover
technique.9 Of these, 246 patients were excluded from deep
venous system surgery in favor of conservative therapy and/or
superficial-vein and perforator treatment.10,11
Selection criteria. All patients presented a deep ve-
nous reflux assessed at Kistner grade IV by using descend-
ing venography and duplex scanning.
The CEAP classification was C 6,S E S A P,D P R in 32
patients and C 6,S E C A D P R in 4 patients affected by valve
agenesis. The patients affected by postthrombotic syn-
drome had presented deep venous thrombosis (DVT) al-
most 10 years previously. All patients presented an ulcer
resistant to conservative therapy and superficial and/or
perforator treatments. The ulcer had been active for at least
5 years or had been recurrent in the same period on more
than three occasions. This meant that the ulcer had been
present for a total of at least 3 years and was a source of
major discomfort for the patients.
Criteria for exclusion from neovalve surgery were:
● severely limited ambulation12
● thrombophilic syndrome
● contraindication to anticoagulant therapy
● severe comorbidity
● feasibility of standard techniques (femoral transposi-






n  21 P
Mean age  SD 54  12.3 58  14.5 .249
Age range 34-79 29-82 —
Male:female 9:8 12:9 .775
Postthrombotic:congenital
aplasia 16:1 18:3 .342
Median follow-up (months) 54 5 .000
Follow-up (months) range 31-78 2-29 —
DVT (%) 3 (16%) 0 .06
Pulmonary embolism 0 0 —
Minor complications
(seromas, hematomas) 4 3 .787
Ulcer healing (%) 16 (84%) 20 (95%) .489
Median period of healing
(weeks) 13 10 .112
Period of healing (weeks)
range 4-19 3-18 —
DVT, Deep venous thrombosis.tion,13 valve transplant14,15)Operations are performed under spinal (36) or general
anesthesia (4). Short-time antibiotic prophylactics are ap-
plied (Cefuroxime per body weight). The position of the
patient on the operating table is supine, with the limb
slightly flexed. A lengthwise incision, approximately 10
centimeters long, is made along the projection of the
femoral vein. The valve reconstruction site is decided on the
basis of preoperative inquiries but definitive confirmation
comes only during intraoperative exploration. The vessel
dissection must be sufficient to ensure an adequate control
of the vein. Heparin is administered endovenously so as to
obtain full anticoagulation, and after activated clotting time
(ACT) assessment, the phlebotomy is performed. The
phlebotomy can be either longitudinal, T-shaped, or trans-
versal, depending on the anatomical conditions encoun-
tered. Once the site for the intimal dissection is established,
in accordance with the parietal thickness and how the
vein-wall thickening itself is distributed, we proceed to a
dissection of the valve flap after endophlebectomy (Fig 2).
This dissection is made using an ophthalmic scalpel or
microsurgical scissors. The depth of the valve is calculated
empirically, checking that the flap is sufficiently wide to
occlude the lumen completely. Whether a bicuspid or
monocuspid valve is reconstructed depends on the circum-
ferential distribution of the thrombotic thickening, though
this does not imply variations of a technical nature. At this
point, the technical variation that determines the difference
between the two series comes into play.
In the second series, the free edge of the flap is fixed to
the vein wall by applying a 7/0 suture (Fig 3). This stitch
limits the degree to which the flap can obtrude into the
vessel and fixes it in a semi-open position (Fig 4). In this
way, reattachment to the original vein wall is prevented.
When the valve has been reconstructed, the phlebotomy
below the reconstruction site is sutured, the vessel is
Fig 2. Neovalve construction in postthrombotic syndrome.
p, proximal; d, distal; a, posterior area with endothelium intact;
b, neovalve; c, area of endophlebectomy; d1, end of dissection;
*, suspension stitches; dotted line, line of dissection; green line,
direction and position of the stitched to maintain the valve in
semi-open position.declamped, and the flap is assessed in its working position.
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omy, which is still open, enabling us to check its size and
competence (Fig 5). At the conclusion of the operation,
both groups of patients underwent compression therapy
with a foot-thigh elastic stocking at 35 mm Hg or with
short stretch bandaging. Anticoagulation therapy with en-
dovenous heparin takes place on day 2 after the operation,
and is then replaced by low-molecular-weight heparin
(LMWH) for a period of 30 days. Subsequently, antiplate-
let treatment (clopidogrel 75 mg daily) continues for 6
months, associated with compression therapy. This thera-
peutic approach, which replaces coagulation by means of
oral anticoagulants, was introduced in June 2004, when
evidence of postoperative thrombosis proved insignificant.
Active movement is resumed early on, during the first
postoperative day.
Statistical analysis. Demographic information was
tabulated for all patients and measurements were expressed
as mean standard deviations. Univariate analysis between
the two series was performed by 2 test for the discrete
variables and by Student’s t test for the continuous ones.
The effect of the technical enhancement applied to the
second series on neovalve patency, neovalve competence,
ulcer healing, and ulcer recurrence was examined. All anal-
yses were performed using the SPSS 11.0 statistical package
Fig 3. Neovalve construction in post-thrombotic syndrome.
p, proximal; d, distal; c, collateral ligature; b, suspension stitches;
dotted black line, line of dissection; dotted blue line, free edge of
neovalve; a, sites of stitches fixing the flap in a semi-open position.(SPSS Inc, Chicago, Ill).RESULTS
The neovalve construction technique was first applied
in December 2000. At June 2007, the overall median
follow-up period is 28.5 (range, 2-78). The first series
presents a long-term follow-up (median 54 months, range,
Fig 4. Stylized drawing of the creation of neovalve by parietal
dissection (a) and fixing stitches to avoid re-adhesion (b).
Fig 5. The suture is completed in the proximal part of the phle-
botomy. Valve competence is checked. a, neovalve site; b, neovalve
bulge visible through distal phlebotomy; p, proximal; d, distal.31-78), while the patients of the second series have been
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range, 2-29). During the follow-up period, neovalve com-
petence, neovalve patency, and clinical outcome (ulcer
healing/recurrence) were evaluated (Fig 7, online only).
After the operation, all patients were submitted daily
to duplex scanning examination until discharge, and
then scheduled for this diagnostic evaluation at 1 month,
6 months, 12 months, and yearly thereafter. Postopera-
tive descending venography was performed in 37 limbs;
3 patients were submitted to a second postoperative
venographic examination. Patients were also scheduled
for air-plethysmography 1 month after surgery and
yearly thereafter (Table II). The mortality rate was 0%
and no major complication occurred.
The cumulative occurrence of minor complications was
17.5% (7/40), with no significant differences between the
two series. There were 3 hematomas (2 requiring surgical
hemostasis), 3 seromas, and 1 wound infection.
The cumulative patency rates were 16 cases per 919
patient-months (1.7/100 patient-months) and 21 per 228
patient-months (9.2/100 patient-months), respectively, in
the first and second series. Two early DVTs were detected,
but distal to the neovalve site and not affecting its function;
one late femoro-popliteal DVT occurred in 1 female pa-
tient who resumed oral contraceptives. All DVT episodes
occurred in patients of the first series, only one affecting the
efficacy of the neovalve by occlusion. No pulmonary em-
bolism was detected.
Cumulative neovalve competence was assessed at 85%.
The neovalve was considered competent when the reflux
recorded just below it was less than 1 second. The compe-
tence rate differs considerably between the two series
(P [log-rank] .035). In the first series, 6 neovalve failures were
detected (two early failures, one neovalve disruption after
DVT, and 3 flap collapses), with a cumulative neovalve
competence assessed at 1.6/100 patient-months (13 cases
per 803 patient-months). To date, no neovalve failure has
been detected in the second series, with a cumulative
neovalve competence assessed at 9.2/100 patient-months
(21 cases per 228 patient-months).
Neovalve competence rates for patients of the first and
the second series are demonstrated in Kaplan-Meier curves
Table II. Plethysmographic parameters: preoperative and
Plethysmographic parameters n






Venous filling index (mL/s)
cumulative 40
Ejection fraction (%)
cumulative 40in Fig 6. Neovalve failure tends to occur more frequentlyduring the first and second postoperative year, while late
deterioration patterns are still unknown.
In terms of the clinical outcome, cumulative ulcer
healing was 7.7/100 patient-months (16 cases per 206
patient-months) in the first series and 30.7/100 patient-
months (20 cases per 65 patient-months) in the second.
Recurrence occurred in one case from the first series and
in two cases from the second series with an intention-to-
treat ulcer recurrence rate of 3 cases per 209 patient-
months. The recurrence of the ulcer in the first series was
related to deep reflux recurrence. One of the two second
series cases was related to superficial venous reflux not
present before deep venous surgery. The other was con-
sequent to a local trauma. No significant difference in
ulcer healing and ulcer recurrence rates was detected
between the two groups (Fig 7).
DISCUSSION
Corrective surgery in deep-venous reflux is not prac-
ticed often for reasons not quite known, though many
consider it risky, others think it pointless, and still others
judge it insufficiently validated in time. In actual fact, this
type of surgery is generally non-aggressive and entails a low
rate of complication.4,16,17 The results achieved partly fade
in time due to the evolving nature of the malady, but the
benefits accruing to over half the patients for a period of
over 5 years are by no means negligible. Unfortunately,
diagnostic procedures for pinpointing the hemodynamic
implications of an obstructive process, particularly if it is
linked to associated reflux, are still somewhat inadequate in
this field. This has doubtless restricted indications for treat-
ment. Endoluminal techniques, widespread at arterial level,
are also totally neglected in the field of venous surgery,18
even though the restoration of permeability, performable in
chronic obstructions,1 yields gratifying results.19,20 Neu-
tralizing obstructions does not resolve all reflux problems
and the beneficial effects of corrective surgery in deep-
venous reflux are well described.4,21
Endoluminal techniques for the correction of refluxes
are still at an experimental stage,21,22 and in the neutraliza-
tion of subinguinal refluxes they still present a number of
problems. In such cases, therefore, direct surgery is the only





12 (7.3-19.2) 2.6 (1.2-8.2)
11.5 (6.1-33) 3.8 (1.4-6.4)
34 (18-41) 51 (30-69)
38 (20-56) 45 (35-68)
11.9 (6.1-33) 2.8 (1.2-8.2)
35 (18-56) 48.5 (30-69)posttechnique currently at our disposal but the indications are
e com
ulcer
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drome, where established reflux correction techniques
do not always prove practicable. The search for alterna-
tive routes24-27 is what led us to the invention of the
neovalve, performed without the use of extraneous mate-
rial, but based exclusively on the recycling of thickened
vein-wall tissue to fashion a flap.5 The flap is quite simply a
pocket obtained by dissecting the vein wall: while not
impeding the normal flow of blood, it is able to withstand
the reflux. Initially, the flap was created in such a way as to
leave it “flapping” freely inside the lumen like a flag, and
this because our major concern was not to impede the flow,
thus avoiding a thrombosis at the dissection site. Contrary
to expectations, however, we ascertained a low incidence of
venous thrombosis: only in one case did it occur at the
Fig 6. Cumulativ
Fig 7. Cumulativeneovalve site. In the first series, we encountered two earlythromboses below the valve reconstruction site and one late
thrombosis at the femoro-popliteal level. None occurred in
the second series.6
On the other hand, one possible complication leading
to the early failure of the treatment may have been the
re-adhesion of the flap to the vein wall. How else to explain
why operations which, from the technical point of view
were complete successes, failed to achieve our predefined
goals? For this reason, we decided to modify the position of
the flap, fixing it in the semi-open position so as to prevent
it from sticking to the vein wall.
Accordingly, in the second consecutive series of pa-
tients the flap was fixed in such a way as to impede adhesion.
This modified flap position is closer to the physiological
position28 than it was in the previous series of operations.
petency rate (%).
recurrence rate (%).The fact that no cases of thrombosis occurred in the second
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tion and fixing of a flap are of themselves not thrombo-
genic. We do not know the precise dynamics of the flap:
whether it floats in the lumen like a natural valve, or
whether it closes due to the filling of the valve bulge, which
pushes it towards the opposite side of the vein wall. This
modified technique proves much simpler and safeguards
against possible technical failures associated with inade-
quately fashioned flaps. It can be seen immediately if the
anti-reflux function works, and in cases of non-functioning
or inadequate flaps the defects can be corrected, thus
reducing time spent in the theatre. Probably, the mecha-
nism can be further improved and the procedure needs to
be standardized. The mid-term results are particularly en-
couraging and it would be opportune to inquire into other
elements such as the most suitable reconstruction site (even
if this is often dictated by anatomical factors) or the possi-
bility of creating anti-reflux mechanisms at various levels.
Valve reconstruction is limited by collateral factors such
as parallel refluxes (axial femoral refluxes or reflexive pro-
funda vein), which are a cause of early and late failure.29
Correcting reflux syndrome should not, therefore, be based
exclusively on neutralizing axial reflux but on a precise
strategy aimed at neutralizing all refluxes, or at least the
most significant refluxes based on a hierarchical order. It is
the hierarchy of these refluxes that we are not in a position
to determine, nor indeed where diagnostic inquiries fail.
Hence, even the neutralization of a reflux in the principal
axis can prove insufficient with time, despite being perfectly
efficient with regard to the segment it addresses. We need
to assess whether associated ligatures are opportune or
whether additional techniques such as endophlebectomy
are required.30 This would aim at maintaining the benefits
achieved by the neovalve in order to prevent a deterioration
of results.
CONCLUSION
The role of corrective surgery in the deep vein system,
either to obtain healing of ulcers resistant to conservative
treatment or to resolve significant symptoms, is still a
matter of some controversy.23 Deep neovalve construction
can be performed in highly selected patients with low
complication rate, high competence rate, high ulcer healing
rate, and low ulcer recurrence. The results have, in the short
term, improved substantially with the new technique. In
patients with a long history of chronic leg ulcers refractory
to treatment, this is an important alternative treatment,
when feasible.
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at www.jvascsurg.org.INVITED COMMENTARYDr Michael C. Dalsing, Indianapolis, Ind
The quest for a substitute venous valve, which would function
long-term and be readily available, has been extensive and often
fruitless. A variety of synthetic, allograft, and even xenograft ve-
nous valves have been manufactured but to date have not been
clinically successful. The only sporadically reported successes have
been with valves made from autologous venous tissue obtained
from distant sites or possible only under very restrictive conditions.
Dr Maleti and his associates have found a way to use readily
available local autologous tissue (the inner vein wall even when
postthrombotic) and a very delicate surgical technique to fashion,
in most cases, a monocusp venous valve. The patients chosen to
undergo this procedure had failed many other attempts to heal
persistent venous ulcers and represent only about a tenth of such
patients his group were treating. In the first series, the valve was
dissected and the vein closed. Although 16 of 19 ulcers healed, the
authors noted that six neovalves demonstrated reflux within a few
years. Innovation requires observation and the imagination to
envision a solution. Since the problem seemed to be re-adherence
of the valve to the vein wall, two sutures were placed to keep thereflect more closely the normal physiologic position of a venous
valve. The result has been a dramatic improvement in the neovalve
competency rate from 1.6/100 patient months to 9.2/100
patient-months and an improved clinical ulcer healing rate of
nearly fourfold.
Who would have thought that the vein wall could be dissected
to make a flap resembling a valve without having the flap immedi-
ately resticking to the wall or result in complete venous thrombo-
sis? Obviously, neither occurs inmost cases and the authors had the
insight and courage to test the hypothesis. The illustrations are
superb, instructive, and clearly demonstrate the thickened post-
thrombotic vein being worked on. The authors demonstrate the
correct position to place sutures to keep the valve in the semi-open
position. The results are well presented, concise, and confirm the
fact that the neovalve works to prevent venous reflux and improve
the clinical condition. I applaud the authors for an innovative
approach to a very difficult clinical problem and for the scientific
method employed in investigating the results. Adoption of the
technique and confirmation of the results by other venous sur-
geons remains the final step for this new surgical technique.
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